A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial
Chiba, Yohei, Sudo, Kazuki, Kojima, Yuki, Okuma, Hitomi, Kohsaka, Shinji, Machida, Ryunosuke, Ichimura, Masahiko, Anjo, Kenta, Kurishita, Kazumi, Okita, Natsuko, Nakamura, Kenichi, Kinoshita, Ichiro, Takahashi, Masanobu, Matsubara, Junichi, Kusaba, Hitoshi, Yonemori, Kan, Takahashi, Masamichi
Published in BMC cancer (09.08.2022)
Published in BMC cancer (09.08.2022)
Get full text
Journal Article
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Okuma, Hitomi S, Watanabe, Keisuke, Tsuchihashi, Kenji, Machida, Ryunosuke, Sadachi, Ryo, Hirakawa, Akihiro, Ariyama, Hiroshi, Kanai, Masashi, Kamikura, Masahisa, Anjo, Kenta, Hiramitsu, Akari, Sekine, Shigeki, Okita, Natsuko, Mano, Hiroyuki, Nishikawa, Hiroyoshi, Nakamura, Kenichi, Yonemori, Kan
Published in Clinical cancer research (15.12.2023)
Published in Clinical cancer research (15.12.2023)
Get full text
Journal Article